Patents by Inventor Sumit K. Chanda

Sumit K. Chanda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
    Patent number: 10864217
    Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV).
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: December 15, 2020
    Assignees: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, SALK INSTITUTE FOR BIOLOGICAL STUDIES
    Inventors: Lars Pache, Sumit K. Chanda, Mitchell Dennis Vamos, Nicholas David Peter Cosford, Peter Teriete, John Marlett, Arturo Diaz, John A. T. Young
  • Use of Inhibitor of Apoptosis Protein (IAP) Antagonists in HIV Therapy
    Publication number: 20200121693
    Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV).
    Type: Application
    Filed: May 24, 2019
    Publication date: April 23, 2020
    Inventors: Lars PACHE, Sumit K. CHANDA, Mitchell Dennis VAMOS, Nicholas David Peter COSFORD, Peter TERIETE, John MARLETT, Arturo DIAZ, John A.T. YOUNG
  • Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
    Patent number: 10300074
    Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV). Described herein is the use of IAP antagonists in the treatment of human immunodeficiency virus (HIV) in a mammal, alone or in combination with other therapeutic agents used in HIV therapy. In one aspect, provided herein is a method of treating human immunodeficiency virus (HIV) in an individual in need thereof comprising administering a therapeutically effective amount of at least one inhibitor of apoptosis proteins (IAP) antagonist.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: May 28, 2019
    Assignees: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE, SALK INSTITUTE FOR BIOLOGICAL STUDIES
    Inventors: Lars Pache, Sumit K. Chanda, Mitchell Dennis Vamos, Nicholas David Peter Cosford, Peter Teriete, John Marlett, Arturo Diaz, John A. T. Young
  • Use of Inhibitor of Apoptosis Protein (IAP) Antagonists in HIV Therapy
    Publication number: 20170196879
    Abstract: Provided herein is the use of compounds that modulate the activity of inhibitor of apoptosis proteins (1APs), alone or in combination with other therapeutic agents, in the treatment of human immunodeficiency virus (HIV). Described herein is the use of IAP antagonists in the treatment of human immunodeficiency virus (HIV) in a mammal, alone or in combination with other therapeutic agents used in HIV therapy. In one aspect, provided herein is a method of treating human immunodeficiency virus (HIV) in an individual in need thereof comprising administering a therapeutically effective amount of at least one inhibitor of apoptosis proteins (IAP) antagonist.
    Type: Application
    Filed: June 4, 2015
    Publication date: July 13, 2017
    Inventors: Lars PACHE, Sumit K. CHANDA, Mitchell Dennis VAMOS, Nicholas David Peter COSFORD, Peter TERIETE, John MARLETT, Arturo DIAZ, John A. T. YOUNG
  • Identification of cellular targets for biologically active molecules
    Publication number: 20030170642
    Abstract: A genetic screening methodology for rapid identification of candidate targets of any small molecule cellular effectors and other signals and modulators of cellular functions and pathways is provided. The effect of a small molecule or other signal on a cell is titrated by expressing within the cell cDNA that encodes a polypeptide that is the molecular target or that is responsible for directly or indirectly producing the molecular target.
    Type: Application
    Filed: March 12, 2002
    Publication date: September 11, 2003
    Applicant: IRM, LLC
    Inventors: Jeremy S. Caldwell, Sumit K. Chanda, Nikunj V. Somia, John B. Hogenesch, Michael P. Cooke, Pedro Aza-Blanc